Groups of 5 male monkeys were fed 0, 0.01, 0.03, 0.1 and 0.3mg/kg/day of methylmercury chloride (as Hg) for 52 months.
prominent feature.
The lesions in the 0.1mg/kg/day group were more extensive and frequent, and more advanced in terms of tissue destruction than those in the 0.3mg/kg/day group, probably due to the protracted course of poisoning in the former group. No alteration was observed in the cerebellar cortex and white matter, spinal cord and peripheral nerves. Tubular degenerations predominant in the proximal tubules of the kidney were also ascribed to the feeding of the test material.
Dose-related Hg accumulations were found in the central nervous system, in which the cerebrum showed the highest levels of Hg, nearly 100% as methyl Hg. Higher Hg accumulations which did not appear to be dose-related were present in the liver and kidney.
One animal from each of the 0.3 and 0.1mg/kg/day groups, to which the administration of the test material was suspended on the 151st and 541st days (5.0 and 17.8 months), respectively, survived the whole experimental period with complete or partial recovery from clinical signs. Histopathologically, however, extensive or localized cortical lesions persisted in these two animals. The high Hg levels in the hair at the time of suspension of administration of the test material decreased to the control level on the 644th and 1094th days (21.2 and 36.0 months), respectively.
Although the Hg levels in various organs were very low, they were still higher, especially in the animal in the lower dose group, than those of the control, and the mercury contained was exclusively inorganic.
The animals of the 0.03 and 0.01mg/kg/day groups survived the experimental period without revealing any clinical signs, except a reduction in body weight gain in the former group at the later stage. The total amounts of the test material ingested in the groups were 39.6 and 13.2 mg/kg as Hg, respectively.
In the hematological examinations no specific change was observed. In the blood biochemical examinations, there was no significant change, except elevation of urea-N after 30 months in the 0.03mg/kg/day group.
The Hg levels in the hair in the 2 groups *3 33 Hiyoshi-Honcho, Kohoku-ku, Yokohama, 223, Japan *4 3-14-36 Kugayama, Suginami-ku, Tokyo, 168, Japan
Introduction
It is well recognized that methyl mercury is a hazardous pollutant in the light of the occurrence of mass and sporadic poisoning cases in man in several countries including Japan, and the peculiar and irreversible neurological manifestations of methyl mercury poisoning have been designated as Hunter-Russel syndrome.
In order to obtain basic data for estimating a tolerable amount of methyl mercury in man, a 52-month toxicity study of methylmercury chloride (MMC) in monkeys was performed at the request of the WHO. The present paper includes the results of the interim reports' of this study, which provided a part of the data of toxicological parameters up to 24 months.
Methods
Test material. MMC used in the experiment was synthesized by the authors according to Marvel and Gould, 2) and had a purity of 99%.
Animals and diet. Quarantined male Macaca mulatta and Macaca fascicularis, imported from the Southeast Asian countries, were fed a diet of commercial monkey pellets (Funabashi Farm Co., AM-1) with fruits and vegetables, and were allowed free access to tap water. The animals were housed in air-conditioned monkey rooms.
Experimental procedure. Groups of 5 male monkeys, each consisting of 3 Mac. mulatta and 2 Mac. fascicularis, were orally administered 0 (control), 0.01 (L1), 0.03 (L2), 0.1 (H1), and 0.3 (H2) mg/kg/day of MMC as Hg for 52 months (except holidays) in pellets; for the dosing, pellets containing MMC at two different concentrations were fed, so as to give the desired doses, every morning just before the animals were given the regular diet. Details of the administration method were described in the interim report1). A mixture of freeze-dried eggs with MMC (to disguise the odor of MMC) is accepted by monkeys, facilitating long-term experiments without reducing feed intake.
Each animal was numbered from No. 1 to 5 for the control, No. 11 to 15 for group L1, No. 21 to 25 for group L2, No. 31 to 35 for group H1 and No. 41 to 45 for group H2. During the administration period, general appearance was observed daily, and measurements of body weight, determinations of total mercury (atomic absorption method) in the hair and blood, and serumbiochemical examinations (protein, biuret method; albumin, Rutstein's method; A/G ratio and glucose, glucose oxidase method; urea-N, DAM-TSC direct method; GOT and GPT, Reitman-Frankel's method; ALP, Kind and King's method; total cholesterol, Zak's method) as well as hematological examinations (numbers of red and white cells, hemocytometer; hemoglobin, cyanmethemoglobin method; hematocrit, capillary method) were conducted at appropriate intervals.
The surviving animals at 52 months as well as dead or moribund animals during the experiment were autopsied for analysis of mercury in organs and histopathological examinations. All the animals except the dead ones were sacrificed by the intravenous perfusion of isotonic sodium chloride solution, followed by 10% neutral formalin, under pentobarbital anesthesia.
Mercury determinations in most organs were made for both total mercury and mercury in the form of methyl mercury.
The determination of methyl mercury was performed by ECD-gas chromatography after pretreatment of tissues by the papain decomposition method.
Histopathological examinations were carried out on all animals except one (No. 35) in group H1, which was discarded because of advanced autolysis.
The brain, spinal cord and peripheral nerves were fixed in 10% buffered neutral formalin, embedded in paraffin, and examined histologically with hematoxylin-eosin, KluverBarrera, and Bodian stains. The other organs were also examined with hematoxylin-eosin stain.
In order to investigate the reversibility of the damage to the central nervous system caused by MMC, its administration was stopped to one animal each (No. 32 and No.42) in groups H1 and H2 at the onset of neurological signs.
Statistical analysis
Data are given as the mean with standard deviation, and the significance of differences was evaluated by using Student's t-test.
Results

General appearance
All the animals in groups H2 and H1 exhibited characteristic neurological signs, including slow movement, ataxia, visual disturbance, blindness, reactive spasm to contact stimulus, intention tremor, loss of reflex to stimuli and paralysis, at 62 and 181 days (2.0 and 6.0 months) on average, respectively, during which period the total amounts of MMC (as Hg) ingested were 15.9 and 15.3mg/kg, respectively (Table 1) .
Four animals of group H2 died or were sacrificed when they became moribund between the 57th and 70th days (1.9 and 2.3 months). The remaining animal (No. 42) of this group showed slight neurological symptoms on the 73rd day (2.4 months), when the administration of MMC was stopped.
Since this animal became quite healthy about a month later, the administration of MMC was resumed on the 133 rd day (4.4 months).
Gradually the feed intake decreased and the pellets containing MMC was entirely rejected by the animal on the 151st day (5.0 months), when the administration of MMC was stopped again. At this time no noticeable neurological signs were present. Thereafter, the animal survived the entire experimental period in a good physical condition.
Four animals of group H1 died or were sacrificed between the 173rd and 242nd days (5.7 and 8.0 months). The remaining animal (No.32) of this group was severely ill on the 541st day (17.8 months) when movement of the extremities had become impossible after the appearance of various neurological signs. On this day the administration of MMC was stopped. The physical condition recovered gradually and the animal became able to take pellets voluntarily with its left hand. Around 24 months it became quite healthy except for a slight paralysis of the left leg, which persisted until the end of the experiment at 52 months.
None of the animals of groups L2 and L1 revealed any noticeable signs throughout the experimental period, except that a lean appearance was noted in group L2 at the later stage of the experiment.
The total amounts of MMC (as Hg) ingested during 52 months were 39.6 and 13.2mg/kg, respectively, in groups L2 and L1 (Table 1) . 2. Body weight (Fig. 1) Group H2 showed a sharp decrease in the body weight from about 6 weeks (1.4 months). Animal No. 42 of this group gained body weight after suspension of MMC administration on the 151st day (5.0 months) and reached the level of the control at around 30 months.
In group H1, a gradual decrease in body weight was seen from about 26 weeks (6.1 months). Animal No. 32 of this group showed a sharp gain in body weight after suspension of MMC administration on the 541st day (17.8 months) and reached the level of the control at around 26 months.
Group L2 showed a slight reduction in body weight gain until about 30 months.
Thereafter, no increase in body weight was noted in this group. The body weight in group L1, whcih showed slightly reduced gain at the early stage, reached the level of the control at about 37 weeks (8.5 months), and hardly any difference from the control was found thereafter. 3. Hematological findings ( Table 2) Group H1 did not show any significant changes in the numbers of red and white blood cells, hemoglobin and hematocrit at 6 months, when the toxic symptoms were imminent.
The lower dose groups showed no significant change during the experimental period, except for a significant decrease in hematocrit in group L2 at 42 months and in hemoglobin in group Li at 52 months.
At 36 months and thereafter the hematocrit tended to decrease, though not significantly, in both groups.
4. Biochemical analysis of serum (Table 3) The only serum constituent to show a change ascribable to the administration of the test sample was urea-N. Statistically significant elevations, though not large, of urea-N were consistently observed from 30 months after the start until the end of the experiment in group L2. 5. Mercury concentration in the hair (Table 4 , Fig. 2 ) A good correlation between the daily dose of MMC and the Hg level in the hair was evident in the analyses made on the 56th to 277th days (1.8 to 9.1 months). The Hg level in group H2 on the 56th day (1.8 months), when one animal of the group revealed overt neurological signs, was 202.06ppm (104. 5-350.4 (Table  5 , Fig. 3 , Fig. 4 ) Determination of mercury was made in both whole blood and red blood cells.
The Hg levels in the blood of four animals Animal No. 32 of group H1, to which the administration of MMC was stopped on the 541st day (17.8 months), showed 0.378ppm for the whole blood in the analysis made after 5 days. The Hg level in the blood of this animal returned to the control level at 30 months.
The Hg levels in the blood of animals of groups L2 and L1 peaked at 30 months, when values of 1.422ppm (0.962-1.606) and 0.474ppm (0.414-0.541), respectively, for the whole blood, and 3.046ppm (2.294-3.569) and 1.133ppm (1.096-1.164), respectively, for the red blood cells were found. Thereafter, the Hg levels decreased gradually and rather erratically until 52 months, when they still showed higher values, 0.607 and 0.298ppm, respectively, for the whole blood, and 1.285 and 0.612ppm, respectively, for the red blood cells, than the control. 7. Mercury concentration in the organs (Table  6 ) In four animals from each of groups H2 and H1 that died or were sacrificed at the earlier stages of the experimental period, mean total Hg was 24.409 and 13.332ppm in the cerebrum, 18.245 and 9.851ppm in the cerebellum, and 7.497 and 6.417ppm in the spinal cord, respectively. In these animals nearly 100% of total Hg was found to be methyl Hg in the cerebrum, whereas only about 60% of total Hg was methyl Hg in the cerebellum.
In organs other than the central nervous system, high values of total Hg were found in the liver, 42.210 and 45.264ppm, and in the kidney, 39.965 and 72.346ppm for groups H2 and H1, respectively, with lower levels in the spleen, 21.035 and 12.125ppm, respectively.
It should be noted that in group H2 the total Hg levels in the liver and kidney were about the same, and Hg in the liver was almost all methyl Hg, whereas the majority of Hg in the kidney was inorganic, and in group H1 the Hg level in the liver was about the same as that in group H2, about half of it being methyl Hg, while total Hg in the kidney far exceeded that in group H2.
In one animal from each of groups H2 and H1, which survived the entire experimental period after suspension of MMC administration at earlier stages, the Hg levels in various organs examined were still higher than those of the control, and the animal from group H1 showed 2.7 to 10.9 times higher values, varying from organ to organ, as compared with the animal from group H2. It is noteworthy that methyl Hg was not found at all in these two animals.
In groups L2 and L1, the Hg levels in organs were evidently dose-dependent.
In the central nervous system the hypothalamus showed the highest Hg level, followed by the cerebrum, cerebellum and spinal cord in that order, ranging from 1.080 to 3.283ppm in group L2 and from 0.554 to 0.978ppm in group L1.
The frontal and occipital lobes showed almost the same amounts of Hg. In these two groups, the methyl Hg level was very low in the cerebellum, in contrast to fairly high levels in the cerebrum. Among various organs the kidney showed the highest Hg level, 35.224ppm in group L2 and 10.775ppm in group L1, followed by the nail, liver and central nervous system in that order. The ratio of methyl Hg to total Hg was considerably lower in the kidney and cerebellum than in other organs.
Throughout all the groups, fairly high ratios of methyl Hg to total Hg were noted in the muscle. The adipose tissue showed the lowest amount of mercury among the organs analyzed. The adipose tissue in group L1 showed almost the same level as the control, in contrast to other organs, in which Hg levels were still considerably higher than those of the control.
Histopathological findings
Nervous system a) Group H2, consisting of 4 animals sacrificed at 57 to 70 days (1.9 to 2.3 months) after the start of MMC administration (No. 41, 43, 44 and 45).
Cerebral cortex: The severest lesions were found in the occipital lobe in all cases, particularly in the striate area, extending to the neighboring cortex. Severe changes were also seen in the precentral and postcentral gyri in 2 and 3 cases, respectively.
The interior frontal gyrus to the insula and some parts of the temporal gyri occasionally showed lesions (No. 41 and 43). In one case (No.43), moderate change was present in the orbital gyrus.
The histopathological features of cortical lesions consisted of the degeneration or loss of nerve cells, the proliferation of plump astrocytes and microglias and the rarefaction of nervous parenchyma.
Degenerated neurons often appeared to be pyknotic with eosinophilic cytoplasm.
The proliferation of plump astrocytes usually corresponded to the degree of neuronal loss, while it appeared infrequently in the absence of marked degeneration of nerve cells. Elongated microglias were found to be abundant at the margins of lesions. Tissue loosening was conspicuous in severely affected areas and in the 4th layer of the cortex. These changes can be summarized as a primary destruction of cortical neurons and resulting reactive gliosis.
The vertical extent of the cortical lesions seemed to be dependent on the degree of local alteration. In the severest instance the loss of neurons involved the entire cortical layers, while being restricted to the superficial layers in the mild case.
Cerebral white matter:
The white matter was often affected under the deteriorated cortex, but lacked lesions in the deeper parts.
Basal ganglia and diencephalon: There was no remarkable change in the basal ganglia except for a small focus of lesion in the medial nucleus of the thalamus in one case (No. 44).
Midbrain, pons and medulla oblongata: Loosening of nervous parenchyma with a slight proliferation of microglias and axonal swelling was found in the tegmentum of the brain stem in one case (No. 41). The olivary nucleus of the same case showed some loss of neurons and proliferation of microglias.
Cerebellum: No changes were observed in the cortex and white matter.
In the dentate nucleus, slight to moderate loss of neurons, proliferation of microglias and swelling of axons were encountered in three cases (No. 41, 44, and 45). Cerebral cortex: The first major lesion existed in the occipital lobe in all cases. The lesion extended from the striate area to the medial convolutions of the cerebral hemisphere, involving the lateral limbic to posterior parietal cortex and the ventral occipital to posterior temporal cortex. The changes in the striate cortex were extensive in 2 cases (No. 31 and 33) and localized in the cortical surface in one case (No. 34).
The second major lesion was present in the parietal lobe, where cortical involvement of moderate to severe degree was seen in the precentral and postcentral gyri. The insular and temporal regions were severely affected contiguous to the parietal lesions.
In the frontal lobe, a few localized lesions existed in some parts of the middle and interior gyri.
The histopathological characteristics of group H1 were essentially the same as those in group H2. However, there was some difference between the two groups in the following respects. First, lesions of group H1 were more extensive and frequent than those of group H2 as represented by the insular and temporal regions. Second, the cortical lesion of group H1 demonstrated a more advanced stage of tissue destruction with a tendency for scarring. Cerebral white matter:
No remarkable changes were observed in the white matter except for the subcortical area, where numerous plump astrocytes appeared adjacent to the involved cortex.
Basal ganglia and diencephalon: Small foci of neuronophagia were present in the medial nucleus of the globus pallidus and of the thalamus in one case (No. 33).
Midbrain, pons and medulla oblongata: Focal loss of neurons associated with microglial proliferation and a spongy state were found in the tegmentum of the pons in one case (No. 33). 
Cerebellum:
There was no particular alteration of the cortex and white matter. histologically. There were no specific changes in these organs except the kidney.
In the kidneys of the animals that had died or been sacrificed at the earlier stages of the experiment in groups H2 and H1, tubular lesions were consistently observed.
In one case (No. 41) of group H2, marked congestion and hemorrhage were noted in the interstitium.
There was no pathological change in the glomerulus except for moderate to marked hyperemia in two and one cases of groups H2 and H1, respectively. Desquamation of degenerated tubular epithelia with pyknosis or karyorrhexis, and/or localized loss of epithelium were observed mainly in the proximal and occasionally in the distal tubules in all cases of both groups. Two animals in each of groups H2 and H1 (No. 41, 43, 31 and 34) showed moderate to marked swelling of epithelia predominantly in the proximal tubules.
The swollen epithelia were often strongly eosinophilic, detached from the basement membrane, and obstructed the tubular lumen. Tubular dilation was observed in two and one animals (No. 41, 44 and 33) of groups H2 and H1, respectively, among which the animal in group H1 revealed especially marked dilation with flattened epithelia throughout all layers of the cortex.
One animal (No. 42 and 32) in each of groups H2 and H1, which survived for the whole experimental period after suspension of MMC administration, showed no pathological change, except for the presence of basophilic tubules with epithelial cells showing increased nuclei in the case of group H1 (considered to represent tubular regeneration).
In groups L2 and L1 no pathological alteration was present in the organs including the kidney. Discussion 1. Clinical neurological signs and dose of MMC. Neurological signs, consisting of slow movement, ataxia, visual disturbance, blindness, reactive spasm to contact stimulus, intention tremor, loss of reflex to stimuli and paralysis, appeared at the two higher dose levels. The times in days (on average) required for onset of neurological signs were 62 and 181 days (2.0 and 6.0 months), respectively, in groups H2 and H1, during which period the mean total intakes were 15.9 and 15.3mg Hg/kg of MMC, respectively. Groups L2 and L1 did not reveal any neurological signs except for a reduction in the body weight in the former group, though the mean total intakes of MMC during 52 months were 39.6 and 13.2mg Hg/kg, respectively. These results clearly demonstrate that development of neurological signs is dependent on two factors; the daily dose and the total intake of MMC. Moreover, the critical daily dose for neurological manifestations of MMC toxicity seems to lie in the very narrow dose range of 0.1 to 0.03 mg/kg/day.
Nordberg et al.t1 fed 0.5 to 1mg Hg/kg/day of radioactive methylmercury to 6 squirrel monkeys. Two animals, which received the agent for 4 and 5 weeks, respectively, developed a common pattern of clinical signs, but 2 animals given the agent for 3 weeks did not. Shaw et al.3) carried out acute and chronic studies on methylmercury hydroxide in 12 rhesus monkeys.
Two animals, which received 2mg/ kg/day for 17 and 18 days in the acute study, and 4 animals, which received 0.5 to 0.8mg/kg/day for 3 to 8.5 months in the chronic study, revealed neurological signs, but there was little difference between the acute and chronic group in terms of histopathological findings. Garman et al.4) gave MMC orally to 14 male squirrel monkeys with various dose regimens. Three out of 6 animals which received a single dose of 4mg Hg/kg revealed neurological signs between 46 and 730 days (1.5 to 24 months) after the dosing, and the remaining 3 did not. Seven animals which received a priming dose of 1mg Hg/kg plus a maintenance dose of 0.1mg Hg/kg/wk for 222-365 days (7.3-12 months) did not show any neurological signs. One out of 12 animals which received a priming dose of 2mg Hg/kg plus a maintenance dose of 0.2mg Hg/kg/wk, and 4 animals which received a priming dose of 4mg Hg/kg and a maintenance dose of 0.4mg Hg/kg/ wk, showed neurological signs on the 90th day (3.0 months), and between the 34th and 127th days (1.1 and 4.2 months), respectively. The neurological signs observed were blindness, weakness with tremor, ataxia, poor coordination, astereognosis and a loss of proprioceptive sense. Since fairly high priming doses were employed in these experiments, it is difficult to deduce the critical daily dose necessary for producing neurological signs. However, it can at least be said that the maintenance dose of about 0.014mg Hg/day (0.1mg Hg/kg/wk) was a non-effective dose in terms of clinical toxic manifestations. Recently Sato et al.t2 reported that the total intake of MMC required for producing severe neurological signs in monkeys given a daily dose of 0.21-0.23mg Hg/kg was 11.5-14.3mg Hg/kg. They also observed that the total intakes required for development of nystagmus in monkeys given daily doses of 0.02-0.03mg Hg/ kg or 0.09-0.23mg Hg/kg were 5.7-9.0mg Hg/kg or 1.2-2.6mg Hg/kg, respectively. Willes et al.5) dosed four infant monkeys (Mac. fascicularis) orally with 0.5mg Hg/kg/day as methylmercury chloride.
The first toxic signs were observed at 28-29 days after the start of treatment, when the infants began to stumble and fall while in the exercise cage. Chen et al.6) reported that continuous low-dose exposure of 6 monkeys (Mac. mulatta) to McHg, ranging from 0.08 to 0.125mg/kg/day for up to 1 year, did not seem to affect the monkeys' general well-being. Takeuchi et al.7) reported atactic gait, slow movement, and tonic-clonic convulsion in encephalopathy of cats in the mercury-polluted Minamata area. Koya8) observed similar behavior in cats after repeated oral administration of methyl methylmercuric sulfide (CH3-Hg-S-CH3), bis (methylmercuric) sulfide (CH3 Hg-S-Hg-CH3) and bis (ethylmercuric) sulfide (C2H5-Hg-S-Hg-C2H5) Irukayama et al.9) reported that total intake of MMC necessary to produce poisoning similar to Minamata disease were 8.0-56.0mg/ kg in the cat and 55-135mg/kg in the rat when given at daily dose levels of 0.8-1.6mg/kg and 10-20mg/kg, respectively. Charbonneau et al10). fed two groups of cats for 12-14 weeks with 0.25mg Hg/kg/day of either pure MMC or methylmercury-contaminated fish. Neurological signs consisting of ataxia, intention tremor and impaired righting reflex and convulsions developed after 77 and 87 days on average, respectively, during which period total doses of 19.2 and 18.0mg Hg/kg was ingested, respectively. Verschuuren et al.11, 12) reported, in shortterm and long-term (2 years) studies on MMC in the rat, that toxic signs developed at 250ppm of MMC in the diet after 1 week with a total intake of 91mg/kg for females and 103mg/kg for males, and at 25ppm (2.5mg/kg/day) after 9-12 weeks, by which time the intake totalled 14-19mg/body, whereas no such signs were seen at 2.5ppm after 2 years, when 28.5mg/body of MMC had been consumed.
The toxic signs consisted of bent back, piloerection, unsteady gait and reluctance to move.
Fehling et al13). gave MMC to three groups of 10 rats on each of two consecutive days by gastric intubation at total dosages of 40, 20 and 0mg Hg/kg of MMC. The rats were examined neurologically by means of the tumble test, rod test and tilting plane test every other day from Day 4 to Day 15, when they were sacrificed after measurement of the motor nerve conduction velocities in the tail. The 20mg/kg group showed transient neurological signs (only in the tilting plane test) on Day 10, while the 40mg/kg group demonstrated significant neurologic dysfunction by Day 4 with signs of improvement after Day 10. The nerve conduction velocities were slower in the 40mg/kg group than in the controls, indicating a peripheral neuropathy.
Mitsumori et al.14) gave diets containing 0.4 to 10ppm of methylmercury chloride (MMC) for 130 weeks to rats.
Neurological signs of crossing reflex and ataxic gait of hindlimbs appeared in several animals at 22 weeks in males and females of the 10ppm group.
From the viewpoint of the total intake required for development of grossly manifest neurological signs in subacute or chronic poisoning by methylmercury, the rat may be far less sensitive to methylmercury toxicity than the monkey, or cat. A preferential binding of red blood cells to methylmercury in this species was postulated as an important factor12). In several studies using monkeys some differences in sensitivity have been found, probably due to differences of strains, and/or experimental procedure, especially dosing schedules.
However, a great similarity in sensitivity was noted between the monkeys studied by the authors and the cats studied by Charbonneau et al.10); very similar experimental procedures were employed in both cases.
Hematology
Hematocrit tended to decrease in groups L2 and L1 at 36 months and thereafter. Group H1 did not show any significant change in hemato- logical examination at 6 months, when the neurological signs were apparent.
Chen et al.6) reported that administration of 0.08-0.125mg/kg/day of methylmercury hydroxide for up to 1 year did not cause any significant change in the hematology.
Rustam and Hamdi15) reported that the complete blood count in 53 patients exposed to methylmercury in Iraq was within normal limits.
The hematologic values for infant monkeys mentioned above5) were within the normal range for Macaca monkeys and did not vary with methylmercury treatment. In the cat10) and rat11), there was no significant change in hematology attributable to the feeding of MMC. Mitsumori et al.14) , however, found that male rats showed anemia after 13 weeks of feeding with 10ppm of MMC.
Blood biochemistry
Statistically significant elevation of serum urea-N in group L2 at the later stage was the only observed biochemical change that might be ascribed to the feeding of MMC. The data on humans15) showed that serum electorolytes and plasma protein were within normal limits. The data on monkeys6), including plasma glucose level, liver function test (alkaline phosphatase, s-GOT, s-GPT), kidney function (Na, K, Ca, creatinine, and BUN) were within the normal limits. In the cat10), an increase in urea-N was observed in the group given MMC, but not in the group given methylmercury-contaminated fish. This increase in urea-N was not accompanied with pathologic changes in the kidneys. In the rat11), kidney damage was evidenced by increases in urinary protein and serum levels of urea-N and ALP in the animals given MMC. Male rats14) given a diet containing 10ppm of MMC showed a higher urea nitrogen level than the control after 26weeks. 4. Mercury concentration in the hair and its relationship with development of neurological signs When the neurological signs were imminent, the Hg level in the hair ranged from 104.5 to 350.4ppm in group H2 and from 110.7 to 200.8 ppm in group H1. Thus, 100ppm Hg in the hair seems to be a critical level for onset of clinical signs under these experimental conditions. The Hg level in the hair at lower dose levels provides some interesting information.
First, no neurological signs were observed in the animals of group L2 in spite of the fact that the peak Hg levels in this group ranged from 124.3 to 178.3ppm, which were as high as those in the hairs of the poisoned animals in groups H2 and H1. This difference of the biological significance of a high Hg accumulation (above the putative critical level) in the hair may be dependent on the rate of Hg accumulation, and this would explain exceptionally high Hg levels sometimes seen in the hair in humans without any symptoms.
Second, the Hg level in the hair of groups L2 and L1 tended to decrease after reaching the peak, in spite of continued administration of MMC.
Based on a study of patients with Minamata disease in Niigata, Japan, Tsubaki et alts reported that the lowest Hg level in the hair was about 100ppm in cases with early onset, and about 50ppm in cases with delayed onset. In the rat11) the terminal Hg levels in the hair were 947ppm and 91.9ppm at a toxic dose level (25ppm diet of MMC) and a sub-toxic dose level (2.5ppm), respectively, in a 12-week study. In a 2-year study, the terminal Hg level was 366ppm in rats receiving a diet containing 2.5 ppm of MMC. 5. Mercury concentration in the blood and its relationship with development of neurological signs (Table 7) Poisoned animals in groups H2 and H1 autopsied at the earlier stage of the experiment showed 12.37 and 8.04ppm Hg (on average), respectively, in the whole blood at the time of sacrifice. Animal No. 32 of group H1, to which the administration of MMC was stopped on the 541st day (17.8 months), showed 0.378ppm in the whole blood in the analysis made after 5 days. This relatively low value was difficult to evaluate in the light of the fact that this animal showed a high Hg level of 3.473ppm at 12 months.
Reports on the Hg concentration in the blood and its relationship with the development of neurological signs are summarized in Table 7 .
The Hg levels in the present experiment were close to those reported in acute studies in r3 Tsubaki, T., Hirota, T., Shirakawa, K., Kondo, K., Sato, T.: The first international congress of toxicology (1977). monkeys3),5) and in a subacute study in the cat10), but were higher than those reported in other monkey studiest1,t2,3),4),6), which agreed in finding roughly 1-2ppm as a critjcal Hg level associated with the development of neurological signs. This discrepancy may be due to the differences in the times of Hg analysis during the poisoning of animals, or in the dosing schedules.
In the rat11),13), extremely high Hg concentrations were required for development of neurological signs. Levels of 0.4-2ppm in patients with early onset and 0.2-0.8ppm in patients with delayed onset of Minamata disease in Niigatat3, and 0. 5-5ppm in patients with methylmercury poisoning in Irag16 were reported as the Hg contents in the blood associated with clinical manifestations of poisoning.
In the present study, the Hg concentrations of groups L2 and L1 decreased erratically, after reaching peaks at 30 months.
The peak Hg concentration for the whole blood in group L2 was 1,422ppm (0.962-1.606), which might be high enough to produce neurological signs as judged from the reports on monkeys mentioned above. This may indicate that the rate of Hg accumulation in the blood is an important factor for the development of clinical manifestations of toxicity, as was the case for the Hg content of the hair.
The gradual decrease in Hg concentrations after reaching the peaks in the blood and hair, in spite of continued administration of MMC, may be due either to lowered absorption rates from the digestive tract, or to increased excretion rates subsequent to acceleration of the metabolism of MMC. Since the change of Hg concentrations of the hair, which may be a route of MMC excretion, showed a similar pattern to those in the blood, it seems likely that lowered absorption rates may be an important factor, though the clarification of the exact mechanism involved will require further investigations. 6. Histopathological findings Consistent and severe lesions in the occipital lobe of the brain, particularly in the striate area, were findings common to groups H2 and H1. These findings are consistent with those reported in experiments on monkeyst1,t2,3)-5). In spite of the essentially similar histopatho- In the cerebellum, no change was observed in the cortex and white matter, but moderate changes were present in the dentate nucleus in group H2.
Slight changes were found in the basal nuclei and brain stem in a few animals in groups H2 and H1.
No change was observed in the spinal cord and peripheral nerves.
It should be noted that extensive or localized cortical lesions persisted in one animal of each of groups H2 and H1, which survived the experimental period with complete or partial recovery from neurological signs after suspension of MMC administration.
Localizations of the lesions of the nervous system in reported animal experiments together with those in the present study are summarized in Table 8 .
In the monkey, lesions in the cerebral cortex were predominant and consistent findings were obtained, except in the acute studies3),5), in which changes in the dentate nucleus, lateral geniculate nucleus, thalamus and pontine nuclei predominated without changes in the cerebral cortex.
In the subacute or chronic studies, the basal nuclei, thalamus, and brain stem nuclei were involved in some experiments, and not in others, probably due to differences of experimental conditions. Lack of lesions in the cerebellar cortex and white matter, and spinal cord was consistently found in all studies.
Peripheral nerves were not involved in most studies except for a slight change in two studies17),t2. In cats, marked changes in the cerebellar cortex accompanied with moder- 
